On remarque une diminution de cette concentration chez des sujets atteints d'ostoporose ou de femmes mnopauses
S2CID 211034183
doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
Kroon, MD, PhD, neonatologist, Erasmus Medical Center Rotterdam, Sophia Childrens Hospital, Department of Pediatrics, Division of Neonatology, Rotterdam, the Netherlands
Cai, H., Griendling, K